Successful management of a simultaneous Aspergillus fumigatus and Absidia corymbifera invasive fungal infection.
Considering the poor prognosis of pediatric patients with invasive fungal infections due to zygomycosis, we present the case of a female adolescent with acute lymphoblastic leukemia, who successfully completed her chemotherapy despite a disseminated double infection with Aspergillus fumigatus and Absidia corymbifera.
Hasan
David
D
Children's Hospital Medical Center, University of Bonn daggerMVZ Labor Dr Krause & Kollegen, Kiel, Germany.
Fleischhack
Gudrun
G
Gillen
Julia
J
Bialek
Ralf
R
Born
Mark
M
Simon
Arne
A
D020095:Absidia; D000293:Adolescent; D000935:Antifungal Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001232:Aspergillus fumigatus; D019468:Disease Management; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D009181:Mycoses / Q000188:drug therapy* / Q000382:microbiology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications* / Q000188:drug therapy
D000935:Antifungal Agents; D000970:Antineoplastic Agents